Cell Biology
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Letaplimab Biosimilar - Anti-CD47 mAb - Research Grade | Anmelden | Letaplimab Biosimilar - Anti-CD47 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Letaplimab Biosimilar - Anti-CD47 mAb - Research Grade | Anmelden | Letaplimab Biosimilar - Anti-CD47 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Licaminlimab Biosimilar - Anti-TNFA mAb - Research Grade | Anmelden | Licaminlimab Biosimilar - Anti-TNFA mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Licaminlimab Biosimilar - Anti-TNFA mAb - Research Grade | Anmelden | Licaminlimab Biosimilar - Anti-TNFA mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Lonigutamab Biosimilar - Anti-IGF1R mAb - Research Grade | Anmelden | Lonigutamab Biosimilar - Anti-IGF1R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Lonigutamab Biosimilar - Anti-IGF1R mAb - Research Grade | Anmelden | Lonigutamab Biosimilar - Anti-IGF1R mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Lorukafusp Biosimilar - Anti-Ganglioside GD2 mAb - Research Grade | Anmelden | Lorukafusp Biosimilar - Anti-Ganglioside GD2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Lorukafusp Biosimilar - Anti-Ganglioside GD2 mAb - Research Grade | Anmelden | Lorukafusp Biosimilar - Anti-Ganglioside GD2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Miromavimab Biosimilar - Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II mAb - Research Grade | Anmelden | Miromavimab Biosimilar - Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Miromavimab Biosimilar - Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II mAb - Research Grade | Anmelden | Miromavimab Biosimilar - Anti-Rabies Virus Strain ERA GP Ectodomain Epitope G-II mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human CDK7 (Cyclin dependent kinase 7) | Anmelden | Mouse Monoclonal antibody to human CDK7 (Cyclin dependent kinase 7) | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human Cyclin H | Anmelden | Mouse Monoclonal antibody to human Cyclin H | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human Cyclin L1 | Anmelden | Mouse Monoclonal antibody to human Cyclin L1 | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human Keratin 5 | Anmelden | Mouse Monoclonal antibody to human Keratin 5 | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human Keratin 5 | Anmelden | Mouse Monoclonal antibody to human Keratin 5 | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human SUMO1 (Small ubiquitin‐related modifier 1) | Anmelden | Mouse Monoclonal antibody to human SUMO1 (Small ubiquitin‐related modifier 1) | ||||||||||||||||
|
||||||||||||||||||
| Mouse Monoclonal antibody to human Tubulin (Beta) | Anmelden | Mouse Monoclonal antibody to human Tubulin (Beta) | ||||||||||||||||
|
||||||||||||||||||
| Bcl-2 Monoclonal Antibody | Anmelden | Bcl-2 Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Myosin Heavy Chain Monoclonal Antibody | Anmelden | Myosin Heavy Chain Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Ki 67 Monoclonal Antibody | Anmelden | Ki 67 Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Caspase 9 Monoclonal Antibody | Anmelden | Caspase 9 Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 6 Monoclonal Antibody | Anmelden | Cytokeratin 6 Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| beta-Tubulin Monoclonal Antibody | Anmelden | beta-Tubulin Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| alpha-tubulin Monoclonal Antibody | Anmelden | alpha-tubulin Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||
| beta I tubulin Monoclonal Antibody | Anmelden | beta I tubulin Monoclonal Antibody | ||||||||||||||||
|
||||||||||||||||||


